-
CellGenix Appoints Leading Experts to Scientific Advisory Board
b3cnewswire
May 16, 2017
CellGenix announced the appointment of highly experienced and internationally respected experts in the field of cell and gene therapy to its Scientific Advisory Board (SAB).
-
Pfizer inks deal with Sangmo for Heamophilia A gene therapy
biospectrumasia
May 12, 2017
There are approximately 16,000 patients in the U.S. and more than 150,000 worldwide with Hemophilia A
-
Cobra Biologics embarks on £15 m gene therapy manufacturing operations expansion
cphi-online
April 21, 2017
Capacity increase in response to customer demand for DNA and viral vector production.
-
Cobra Biologics Invests $19m in Gene Therapy Mfg. Expansion
contractpharma
April 19, 2017
Capacity increase in response to customer demand for DNA and viral vector production
-
Mundipharma partners with Kolon Life Science to market cell-medicated gene therapy
biospectrumasia
April 12, 2017
Invossa is an intra-articular injection that is non-surgical treatment option
-
Gene Therapy: A Breakthrough for Sickle Cell Anemia?
drugs.com
March 02, 2017
Researchers are reporting early success using gene therapy to treat, or even potentially cure, sickle cell anemia.
-
Lonza and Selecta Biosciences in Mfg. Pact
contractpharma
February 17, 2017
Partnership focused on Anc80-AAV-based gene therapy for treatment of methylmalonic acidemia
-
MeiraGTx Provides Clinical Trial Updates for Achromatopsia and Leber's Congenital Amaurosis Ocular G
firstwordpharma
February 09, 2017
MeiraGTx, a New York and London based gene therapy company, announced today the first patient in its clinical study for achromatopsia due to mutations in the CNGB3 gene was treated at the Moorfields Eye Hospital in London.